España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Capricor Therapeutics
CAPR
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.69
0
0.00%
Last update: Jul 19, 4:02 PM
15 minutes delayed
Get Report
Comment
Capricor Therapeutics (CAPR) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Capricor Therapeutics (NASDAQ:CAPR) Stock
Capricor Therapeutics Stock (NASDAQ: CAPR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 02, 2024
Unveiling 6 Analyst Insights On Capricor Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Caprico...
Benzinga Newsdesk
Monday, July 01, 2024
Capricor Therapeutics To Join Russell 2000 An...
Benzinga Newsdesk
Friday, June 28, 2024
What's Going On With Capricor Therapeutics Stock Friday?
Dylan Berman
Capricor Therapeutics Announces Long-Term Ben...
Benzinga Newsdesk
Tuesday, June 25, 2024
Capricor Therapeutics Announces The FDA Has S...
Benzinga Newsdesk
Friday, June 14, 2024
Capricor Therapeutics Files For Mixed Shelf O...
Benzinga Newsdesk
Thursday, June 13, 2024
Pfizer Phase III DMD Gene Therapy Study Misses Goal
Zacks
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
What's Going On With Capricor Therapeutics Stock Tuesday?
Dylan Berman
Capricor Therapeutics Completes Type-B Meetin...
Benzinga Newsdesk
Monday, June 10, 2024
Capricor Advances in DMD Therapy With Positive Study Data
Zacks
Tuesday, June 04, 2024
What's Going On With Capricor Therapeutics Stock Tuesday?
Dylan Berman
Capricor Therapeutics Reports 3-Year Efficacy...
Benzinga Newsdesk
Friday, May 17, 2024
Oppenheimer Initiates Coverage On Capricor Th...
Benzinga Newsdesk
Tuesday, May 14, 2024
Expert Ratings For Capricor Therapeutics
Benzinga Insights
Ladenburg Thalmann Maintains Buy on Capricor ...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ca...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Caprico...
Benzinga Newsdesk
Monday, May 13, 2024
Capricor Therapeutics Expects Available Cash ...
Benzinga Newsdesk
Capricor Therapeutics Q1 2024 GAAP EPS $(0.31...
Benzinga Newsdesk
Thursday, May 09, 2024
Capricor Therapeutics To Present Exosome Plat...
Benzinga Newsdesk
Thursday, April 25, 2024
HC Wainwright & Co. Reiterates Buy on Caprico...
Benzinga Newsdesk
Wednesday, April 24, 2024
Capricor Therapeutics Announces Type-B Meetin...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Caprico...
Benzinga Newsdesk
Thursday, February 29, 2024
Recap: Capricor Therapeutics Q4 Earnings
Benzinga Insights
Capricor Therapeutics Q4 2023 GAAP EPS $(0.02...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Capricor Therapeutics's Earnings Outlook
Benzinga Insights
Tuesday, February 27, 2024
Capricor Therapeutics Announces Type-B Meetin...
Benzinga Newsdesk
Tuesday, February 20, 2024
Capricor Therapeutics Announces Manufacturing...
Benzinga Newsdesk
Wednesday, January 24, 2024
Capricor Therapeutics Collabores With Nationa...
Benzinga Newsdesk
Thursday, January 11, 2024
Capricor Therapeutics Receives First Mileston...
Benzinga Newsdesk
Friday, January 05, 2024
Cantor Fitzgerald Initiates Coverage On Capri...
Benzinga Newsdesk
Monday, December 11, 2023
Capricor Therapeutics Announces Outcome Of Ph...
Benzinga Newsdesk
Tuesday, November 14, 2023
Capricor Says Its Available Cash & Equivalent...
Benzinga Newsdesk
Capricor Therapeutics Q3 EPS $(0.25) Vs $(0.2...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2023
Benzinga Insights
Monday, November 13, 2023
Preview: Capricor Therapeutics's Earnings
Benzinga Insights
Wednesday, October 25, 2023
Chief Financial Officer at Capricor Therapeutics Exercises Options Worth $6K
Benzinga Insights
Tuesday, October 24, 2023
Capricor Therapeutics Chief Financial Officer Acquires 2,178 Shares After Exercising Company Stock Options
Benzinga Insights
Thursday, October 19, 2023
Capricor Therapeutics And Parent Project Musc...
Benzinga Newsdesk
Thursday, October 12, 2023
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
Lisa Levin
Tuesday, October 10, 2023
Capricor Therapeutics Announces Late-Breaking...
Benzinga Newsdesk
Monday, October 09, 2023
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying
Lisa Levin
Wednesday, October 04, 2023
HC Wainwright & Co. Maintains Buy on Capricor...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, September 29, 2023
US Stocks Turn Lower; Dow Tumbles Over 200 Points
Lisa Levin
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch